|
Number of patients with post-bronchoscopy adverse events, n (%)
|
|
Respiratory events
|
43 (9.4)
|
23 (20.7)
|
0.001
|
24 (10.8)
|
23 (20.7)
|
0.023
|
|
Febrile events
|
48 (10.5)
|
29 (26.1)
|
< 0.001
|
24 (10.8)
|
29 (26.1)
|
0.001
|
|
Hemodynamic events
|
33 (7.2)
|
7 (6.3)
|
0.900
|
16 (7.2)
|
7 (6.3)
|
0.939
|
|
Cardiac events
|
11 (2.4)
|
6 (5.4)
|
0.175
|
10 (4.5)
|
6 (5.4)
|
0.928
|
|
Cerebrovascular events
|
0 (0.0)
|
1 (0.9)
|
0.441
|
0 (0.0)
|
1 (0.9)
|
0.723
|
|
Any adverse events
|
103 (22.3)
|
35 (32.4)
|
0.021
|
49 (22.1)
|
38 (34.2)
|
0.025
|
|
Clinical outcomes
| | | | | | |
|
Hospital length of stay after bronchoscopy, median (IQR)
|
2 (1–12)
|
4 (1–10)
|
0.99
|
1 (1–14)
|
2 (1–11)
|
0.744
|
|
ICU admission after bronchoscopy, n (%)
|
18 (3.9)
|
9 (8.1)
|
0.159
|
8 (3.6)
|
9 (8.1)
|
0.135
|
|
7-day all-cause mortality, n (%)
|
5 (1.1)
|
3 (2.7)
|
0.399
|
5 (2.3)
|
3 (2.7)
|
1.000
|
